According to Zhitong Finance App News, Botuo Biotech (688767.SH) disclosed its 2026 third quarter report. In the first three quarters, the company achieved revenue of 312 million yuan, an increase of 1.33% over the previous year; net profit loss to mother of 166.67,800 yuan; loss of 22.297,200 yuan after deducting non-net profit; and basic earnings per share - 0.11 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.